NAPLES, FL / ACCESSWIRE / December 5, 2024 / Stemtech Corporation (OTCQB:STEK), a US-based company announced this past Tuesday its planned merger ("Merger") with Seacret Direct, LLC ("VIÁGO") and now announces a proposal for a Reverse Takeover (RTO) of Eevia Health Plc ("Eevia"), a Finnish producer of bioactive organic Arctic plant extracts and nutraceuticals and has its common stock listed on the Swedish Spotlight Stock Market under the symbol "EEVIA". This strategic RTO marks a major milestone in the evolution of the combined companies, intending to create a vertically integrated health, wellness, and lifestyle entity that manufactures its own products and is positioned for significant growth in the global marketplace.
NAPLES, FL / ACCESSWIRE / December 4, 2024 / Stemtech Corporation (OTCQB:STEK) is pleased to announce the merger agreement with Seacret Direct / VIÁGO, progressing their plan to establish a global leadership position in defining the future of lifestyle, health and longevity. The transaction will be completed through the issuance of 13 million preferred shares with a stated value of $2.50 per share.
NAPLES, FL / ACCESSWIRE / November 20, 2024 / Stemtech Corporation (OTCQB:STEK) and Seacret Direct, LLC (doing business as VIÁGO) are pleased to announce they have reached an agreement in principle to merge their businesses. This merger represents a transformative step forward for both organizations, aiming to drive significant growth and enhance shareholder value.
| Specialty Retail Industry | Consumer Discretionary Sector | Charles S. Arnold CEO | OTC PINK Exchange | 85859W102 CUSIP |
| US Country | 1 Employees | - Last Dividend | 5 Aug 2021 Last Split | - IPO Date |
Stemtech Corporation operates within the niche market of stem cell nutrition, focusing on the development of science-based products designed to enhance and support the body's stem cell processes. This American company, with a geographical reach that spans the Americas, Latin America, and Asia, leverages the potential of stem cells for maintaining optimal health. By developing dietary supplements that support the proliferation, circulation, and tissue migration of stem cells, Stemtech aims to facilitate the body's natural renewal processes. Based in Miramar, Florida, Stemtech stands at the forefront of utilizing stem cell nutrition to promote overall wellbeing.
A comprehensive dietary supplement regime designed to enhance the body’s natural stem cell functions, including their release, circulation, and tissue migration, thereby supporting the body's self-renewal capabilities.
An advanced formulation that specifically aids in the release of stem cells, ensuring a higher number of these vital cells are available to perform rejuvenating and repair functions throughout the body.
This product focuses on improving the circulation of stem cells in the bloodstream, ensuring these cells can reach the areas of the body where they are most needed for repair and regeneration.
MigraStem is designed to facilitate the efficient migration of stem cells to various tissues, enhancing the body’s natural repair and regeneration processes at the cellular level.
Targets skin rejuvenation, utilizing stem cell nutrition to promote the natural renewal of skin cells, thereby improving skin texture and appearance for a healthier, more youthful look.
A specialized product within the DermaStem line, focused on lifting and firming the skin through enhanced stem cell activity, providing visible anti-aging benefits.
A unique oral care product that harnesses the power of stem cell nutrition to improve dental and gum health, promoting oral hygiene and overall wellness.
A dietary supplement designed to diffuse the stress factors affecting cellular health, thereby supporting the body’s overall wellbeing by ensuring stem cells can operate in an optimal environment.